SynopsisThe global market for Actigraphy Sensors and Polysomnography Devices was valued at US$ 1458 million in the year 2024 and is projected to reach a revised size of US$ 2096 million by 2031, growing at a CAGR of 5.4% during the forecast period. An actigraph,.....
SynopsisThe global market for Intraoral Scanner was valued at US$ 472 million in the year 2024 and is projected to reach a revised size of US$ 861 million by 2031, growing at a CAGR of 9.1% during the forecast period. Intra Oral Scanners are one of the most exci.....
SynopsisThe global market for Enteral Feeding Devices was valued at US$ 3404 million in the year 2024 and is projected to reach a revised size of US$ 5316 million by 2031, growing at a CAGR of 6.7% during the forecast period. Enteral feeding device is a medical .....
SynopsisThe global market for Clear-Aligner Treatment was valued at US$ 5055 million in the year 2024 and is projected to reach a revised size of US$ 19630 million by 2031, growing at a CAGR of 21.7% during the forecast period. Clear-Aligner Treatment is orthodo.....
SynopsisThe global market for Cryosurgery Units was valued at US$ 47.3 million in the year 2024 and is projected to reach a revised size of US$ 65.8 million by 2031, growing at a CAGR of 4.9% during the forecast period. Cryosurgery units are surgical instruments.....
SynopsisThe global market for Medical Specialty Enzymes was valued at US$ 924 million in the year 2024 and is projected to reach a revised size of US$ 1328 million by 2031, growing at a CAGR of 5.4% during the forecast period. Medical Specialty Enzymes contains .....
SynopsisThe global market for Orthokeratology was valued at US$ 1827 million in the year 2024 and is projected to reach a revised size of US$ 5533 million by 2031, growing at a CAGR of 17.4% during the forecast period. Ortho-K is a non-surgical refractive treatm.....
SynopsisThe global market for Antihypertensive Beta Blockers was valued at US$ 18500 million in the year 2024 and is projected to reach a revised size of US$ 24340 million by 2031, growing at a CAGR of 4.0% during the forecast period. Antihypertensive beta block.....
SynopsisThe global market for Oncaspar was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 281 million by 2031, growing at a CAGR of 11.4% during the forecast period. Oncaspar is a cancer medicine used in adults and chi.....
SynopsisThe global market for 3D Reconstructed Corneal Model was valued at US$ 23.5 million in the year 2024 and is projected to reach a revised size of US$ 65.6 million by 2031, growing at a CAGR of 15.8% during the forecast period. 3D Reconstructed Corneal Mod.....
